U.S. Global Investors (USGI)’s Jazz Pharmaceuticals JAZZ Stock Holding History

U.S. Global Investors (USGI)’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,000	Closed	-$352K	–	333
2015 Q2	$352K	Buy	+2,000	New	+$359K	0.14%	145
2015 Q1	–	Sell	-5,500	Closed	-$901K	–	350
2014 Q4	$901K	Buy	5,500 +500	+10%	+$83K	0.24%	95
2014 Q3	$803K	Buy	+5,000	New	+$769K	0.23%	117

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

U.S. Global Investors (USGI)'s JAZZ Position: Q3 2015 in Review

U.S. Global Investors (USGI) sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2015, closing a stake of 2,000 shares — an estimated $352K sold.

U.S. Global Investors (USGI) first reported a position in JAZZ in Q3 2014 and held it in 3 quarters. The position peaked at $901K in Q4 2014. 361 funds tracked by Wall St. Rank hold JAZZ as of Q3 2015.

U.S. Global Investors (USGI) reported no remaining Jazz Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
U.S. Global Investors (USGI) sold 2,000 Jazz Pharmaceuticals shares in Q3 2015, an estimated $352K.
U.S. Global Investors (USGI) first reported a position in Jazz Pharmaceuticals in Q3 2014 and held it in 3 quarters.
U.S. Global Investors (USGI)'s Jazz Pharmaceuticals position peaked at $901K in Q4 2014.
361 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2015.

Based on U.S. Global Investors (USGI)'s 13F filing for Q3 2015, filed 13 Nov 2015.